Rybelsus vs. Wegovy What is the Difference?
Weight Loss
Aug 19, 2025
In this article, we will examine the effectiveness of Rybelsus and Wegovy, as both contain the active ingredient Semaglutide. We will also discuss patient suitability, side effects, cost considerations, and insurance coverage.
What is Rybelsus?
Rybelsus improves glycemic control in adults with type 2 diabetes when combined with a well-balanced diet and regular exercise.
It stimulates the pancreas to release insulin and inhibits the liver’s production and release of excess sugar. Additionally, Rybelsus increases feelings of fullness by slowing gastric emptying.
What is Wegovy?
Wegovy is prescribed for weight loss in patients aged 12 years and older with a body mass index of 27 or higher and weight-related medical conditions.
Additionally, Wegovy is beneficial in reducing risks of heart attack, stroke, and cardiovascular death.
For those thinking about transitioning from Mounjaro to Wegovy, it’s important to understand the key considerations involved. Discover the essential steps for switching from Mounjaro to Wegovy to ensure a successful change in your treatment plan.
Wegovy vs. Rybelsus: Is Wegovy the Same As Rybelsus?
Wegovy and Rybelsus are prescribed for different health conditions, come in various forms and strengths, and are administered at different doses.
Form and Frequency
Rybelsus is administered orally, while Wegovy is given via injection.
Dosage
Once-daily Rybelsus tablets are available in three strengths increased every month:
3 mg – initial dose
7 mg – subsequent dose
14 mg – maximum dose available.
Once-weekly Wegovy subcutaneous injection pens come at five strengths increased every month:
0.25 mg – starting dose
0.5 mg – follow-up dose
1 mg – follow-up dose
1.7 mg – maintenance dose
2.4 mg – maintenance dose if the previous one is not offering satisfying results.
Cost
The price for all Wegovy dosage strengths is $388.64 for a 28-day supply, while treatment with Rybelsus costs around $300 per month.
Insurance coverage depends on each individual patient’s specific insurance company and benefits coverage:
Rybelsus is covered for most commercially insured patients under certain conditions
Private health insurance coverage of Wegovy depends on the company’s policy so it is best to ask your insurance representative about whether they cover Wegovy prescriptions.
Side Effects and Safety
Taking Wegovy or Rybelsus carries the risk of such side effects as:
Nausea
Diarrhea
Constipation
Vomiting
Hypoglycemia
Dizziness
Abdominal pain
Allergic reactions
Diabetic retinopathy complications
Thyroid cancer
Pancreatitis
Gallstones.
Research showed that taking Semaglutide imposes lower risk of suicidal thoughts than taking other drugs.
Which is More Effective: Rybelsus or Wegovy?
Wegovy is more effective than Rybelsus due to maintaining higher Semaglutide levels in the blood for longer.
Comparison of the weight loss outcomes by week 26 demonstrated the following:
Wegovy 2.4 mg led to ∼9.9 kg weight loss
Less than 2.4 mg of Wegovy led to ∼4.3 kg weight loss
Rybelsus 14 mg led to ∼2.3 kg weight loss
Rybelsus 7 mg resulted in ∼3.7 kg weight loss.
Rybelsus 50mg per day can support weight loss similar to Wegovy 2.4 mg. However, Rybelsus is only approved in doses up to 14 mg and only as a type 2 diabetes medication.
Understanding how Wegovy compares with other medications, like Zepbound, can provide a clearer picture of your options. Dive into our comparison of Zepbound vs Wegovy to see how these treatments differ in effectiveness and side effects.
Rybelsus vs. Wegovy: Which One Should You Take?
Selection of the most appropriate treatment should be made on an individual basis to best suit the patient’s preferences and specific health needs.
If you’re comparing Wegovy with other medications, it might be useful to explore how it stacks up against Contrave. For a detailed comparison, check out our guide on Contrave vs Wegovy to determine which might be the better choice for your needs.
Key Takeaways
Semaglutide, an active ingredient in both Rybelsus and Wegovy, helps control blood sugar levels and reduces appetite significantly which leads to notable weight loss.
Rybelsus is used in the treatment of type 2 diabetes although it can be prescribed off-label as an anti-obesity drug, while Wegovy shows effectiveness in clinical trials regarding substantial weight loss.
Treatment with Rybelsus or Wegovy comes with the risk of adverse effects, mainly gastrointestinal effects. Semaglutide is contraindicated in patients with specific health conditions, such as medullary thyroid carcinoma.
Wegovy is a more potent anti-obesity drug than Rybelsus as demonstrated by clinical trial outcomes – Wegovy 2.4 mg supports weight loss of ∼11%, whereas Rybelsus 14 mg supports weight loss of ∼4.5% after 26 weeks.
Frequently Asked Questions
Is Rybelsus Approved in Canada?
Rybelsus is approved by Health Canada.
Can I Switch from Rybelsus to Wegovy?
Patients receiving Rybelsus 14 mg can safely transition to Wegovy 0.5 mg the day after their last oral dose.
Is Rybelsus Safer Than Wegovy?
Rybelsus and Wegovy share a side effect profile and are both approved for long-term use, but more side effects were reported by Wegovy users.
Sources:
Questions? Contact us anytime on the site chat or at hello@jill.health
Questions? Contact us anytime on the site chat or at hello@jill.health
What We Treat
About Us
Shop
Questions? Contact us anytime on the site chat or at hello@jill.health
What We Treat
About Us
Shop